{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:54:38Z","timestamp":1791323678998,"version":"4.3.1"},"reference-count":127,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["#302815"],"award-info":[{"award-number":["#302815"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Immunology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.smim.2026.102066","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T21:13:41Z","timestamp":1789161221000},"page":"102066","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Power to the Tregs in transplantation tolerance in LATAM: From the basics to the bedside"],"prefix":"10.1016","volume":"84","author":[{"given":"Karina","family":"Pino-Lagos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1539-2548","authenticated-orcid":false,"given":"Gloria","family":"Soldevila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.smim.2026.102066_bib1","unstructured":"M S. Actividad de donaci\u00f3n y trasplante de \u00f3rganos, tejidos y c\u00e9lulas de Am\u00e9rica Latina y el Caribe:. 2015;5(DONASUR.net:)."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib2","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1084\/jem.179.2.493","article-title":"High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells","volume":"179","author":"Bacchetta","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.smim.2026.102066_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1032575","article-title":"Type 1 regulatory T cell-mediated tolerance in health and disease","volume":"13","author":"Freeborn","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2026.102066_bib4","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.4049\/jimmunol.155.3.1151","article-title":"Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases","volume":"155","author":"Sakaguchi","year":"1995","journal-title":"J. Immunol."},{"issue":"5609","key":"10.1016\/j.smim.2026.102066_bib5","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1126\/science.1079490","article-title":"Control of regulatory T cell development by the transcription factor Foxp3","volume":"299","author":"Hori","year":"2003","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib6","first-page":"723","article-title":"Cell interactions in the induction of tolerance: the role of thymic lymphocytes","volume":"18","author":"Gershon","year":"1970","journal-title":"Immunology"},{"issue":"4379","key":"10.1016\/j.smim.2026.102066_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/172603a0","article-title":"Actively acquired tolerance of foreign cells","volume":"172","author":"Billingham","year":"1953","journal-title":"Nature"},{"issue":"2651","key":"10.1016\/j.smim.2026.102066_bib8","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1126\/science.102.2651.400","article-title":"Immunogenetic Consequences of Vascular Anastomoses between Bovine Twins","volume":"102","author":"Owen","year":"1945","journal-title":"Science"},{"issue":"10","key":"10.1016\/j.smim.2026.102066_bib9","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41577-023-00927-0","article-title":"Author Correction: A guide to thymic selection of T cells","volume":"23","author":"Ashby","year":"2023","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib10","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006957","article-title":"T-cell tolerance: central and peripheral","volume":"4","author":"Xing","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"issue":"7","key":"10.1016\/j.smim.2026.102066_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70118","article-title":"Induced Treg-Derived Extracellular Vesicles Suppress CD4(+) T-Cell-Mediated Inflammation and Ameliorate Bone Loss During Periodontitis Partly Through CD73\/Adenosine-Dependent Immunomodulatory Mechanisms","volume":"14","author":"Rojas","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.smim.2026.102066_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1328193","article-title":"Mechanisms underlying immunosuppression by regulatory cells","volume":"15","author":"Goldmann","year":"2024","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.smim.2026.102066_bib13","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/JLB.3MR0420-533RR","article-title":"T regulatory cells-derived extracellular vesicles and their contribution to the generation of immune tolerance","volume":"108","author":"Rojas","year":"2020","journal-title":"J. Leukoc. Biol."},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib14","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12237","article-title":"Neuropilin-1 is present on Foxp3+ T regulatory cell-derived small extracellular vesicles and mediates immunity against skin transplantation","volume":"11","author":"Campos-Mora","year":"2022","journal-title":"J. Extracell. Vesicles"},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib15","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/icb.2014.77","article-title":"Neuropilin-1+ regulatory T cells promote skin allograft survival and modulate effector CD4+ T cells phenotypic signature","volume":"93","author":"Campos-Mora","year":"2015","journal-title":"Immunol. Cell. Biol."},{"key":"10.1016\/j.smim.2026.102066_bib16","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3389\/fimmu.2019.00882","article-title":"CD4+Foxp3+T Regulatory Cells Promote Transplantation Tolerance by Modulating Effector CD4+ T Cells in a Neuropilin-1-Dependent Manner","volume":"10","author":"Campos-Mora","year":"2019","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib17","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/imm.12483","article-title":"Exogenous interleukin-33 targets myeloid-derived suppressor cells and generates periphery-induced Foxp3(+) regulatory T cells in skin-transplanted mice","volume":"146","author":"Gajardo","year":"2015","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.smim.2026.102066_bib18","doi-asserted-by":"crossref","DOI":"10.1093\/immhor\/vlag019","article-title":"TGF-beta-induced Tregs release extracellular vesicles that modulate CD4+ T-cell proliferation and phenotype in a Nrp1-dependent manner","volume":"10","author":"Moya-Guzman","year":"2026","journal-title":"Immunohorizons"},{"issue":"21","key":"10.1016\/j.smim.2026.102066_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/nu16213655","article-title":"IL-33 Induces a Switch in Intestinal Metabolites Revealing the Tryptophan Pathway as a Target for Inducing Allograft Survival","volume":"16","author":"Pinto","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/j.smim.2026.102066_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1395421","article-title":"Contribution of tryptophan and its metabolites to transplant outcome: a mini-review","volume":"15","author":"Donoso-Meneses","year":"2024","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2026.102066_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15761\/TiT.1000238","article-title":"IL-33 improves the suppressive capacity of human regulatory T cells","volume":"10","author":"Gajardo","year":"2017","journal-title":"Trends Transplant."},{"key":"10.1016\/j.smim.2026.102066_bib22","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686530","article-title":"Highly Purified Alloantigen-Specific Tregs From Healthy and Chronic Kidney Disease Patients Can Be Long-Term Expanded, Maintaining a Suppressive Phenotype and Function in the Presence of Inflammatory Cytokines","volume":"12","author":"Cortes-Hernandez","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol. Rev."},{"issue":"12","key":"10.1016\/j.smim.2026.102066_bib24","doi-asserted-by":"crossref","first-page":"5076","DOI":"10.1182\/blood-2002-09-2798","article-title":"IL-10 and TGF-beta induce alloreactive CD4+CD25- T cells to acquire regulatory cell function","volume":"101","author":"Chen","year":"2003","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.smim.2026.102066_bib25","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1111\/j.1600-6143.2004.00566.x","article-title":"TGF-beta induces Foxp3 + T-regulatory cells from CD4 + CD25 - precursors","volume":"4","author":"Fu","year":"2004","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.smim.2026.102066_bib26","doi-asserted-by":"crossref","first-page":"7282","DOI":"10.4049\/jimmunol.166.12.7282","article-title":"A role for TGF-beta in the generation and expansion of CD4+CD25+ regulatory T cells from human peripheral blood","volume":"166","author":"Yamagiwa","year":"2001","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102066_bib27","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.4049\/jimmunol.169.8.4183","article-title":"Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors","volume":"169","author":"Zheng","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1777669","article-title":"CD4+FoxP3+ T regulatory cells subsets release small extracellular vesicles containing cell death-related proteins as potential mechanism of T cell suppression","volume":"17","author":"Moya-Guzman","year":"2026","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102066_bib29","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1084\/jem.20070719","article-title":"All-trans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of co-stimulation","volume":"204","author":"Benson","year":"2007","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib30","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s10340-017-0944-y","article-title":"Sterile insect technique and Wolbachia symbiosis as potential tools for the control of the invasive species Drosophila suzukii","volume":"91","author":"Nikolouli","year":"2018","journal-title":"J. Pest. Sci. (2004)"},{"issue":"10","key":"10.1016\/j.smim.2026.102066_bib31","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1093\/intimm\/dxx060","article-title":"Generation of allo-antigen-specific induced Treg stabilized by vitamin C treatment and its application for prevention of acute graft versus host disease model","volume":"29","author":"Kasahara","year":"2017","journal-title":"Int. Immunol."},{"issue":"7","key":"10.1016\/j.smim.2026.102066_bib32","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","article-title":"Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells","volume":"184","author":"Thornton","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fimmu.2016.00276","article-title":"Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(-) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans","volume":"7","author":"Elkord","year":"2016","journal-title":"Front. Immunol."},{"issue":"6652","key":"10.1016\/j.smim.2026.102066_bib34","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/39614","article-title":"A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis","volume":"389","author":"Groux","year":"1997","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.smim.2026.102066_bib35","doi-asserted-by":"crossref","first-page":"5986","DOI":"10.4049\/jimmunol.172.10.5986","article-title":"IL-10-secreting regulatory T cells do not express Foxp3 but have comparable regulatory function to naturally occurring CD4+CD25+ regulatory T cells","volume":"172","author":"Vieira","year":"2004","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/nm.3179","article-title":"Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells","volume":"19","author":"Gagliani","year":"2013","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib37","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1038\/s41467-018-07581-4","article-title":"Molecular and functional heterogeneity of IL-10-producing CD4(+) T cells","volume":"9","author":"Brockmann","year":"2018","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib38","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201847121","article-title":"Retinoic acid-induced autoantigen-specific type 1 regulatory T cells suppress autoimmunity","volume":"20","author":"Raverdeau","year":"2019","journal-title":"EMBO Rep."},{"issue":"3","key":"10.1016\/j.smim.2026.102066_bib39","doi-asserted-by":"crossref","DOI":"10.1038\/emm.2017.313","article-title":"Transcriptional regulation and development of regulatory T cells","volume":"50","author":"Lee","year":"2018","journal-title":"Exp. Mol. Med."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib40","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ni1549","article-title":"Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer","volume":"9","author":"Tone","year":"2008","journal-title":"Nat. Immunol."},{"issue":"7282","key":"10.1016\/j.smim.2026.102066_bib41","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nature08750","article-title":"Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate","volume":"463","author":"Zheng","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib42","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2021.04.005","article-title":"Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells","volume":"54","author":"Kawakami","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib43","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/eji.200636435","article-title":"Transient expression of FOXP3 in human activated nonregulatory CD4+ T cells","volume":"37","author":"Wang","year":"2007","journal-title":"Eur. J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib44","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.immuni.2025.10.020","article-title":"FOXP3 expression depends on cell-type-specific cis-regulatory elements and transcription factor circuitry","volume":"59","author":"Umhoefer","year":"2026","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib45","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4049\/jimmunol.178.1.280","article-title":"IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells","volume":"178","author":"Burchill","year":"2007","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2026.102066_bib46","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1002\/eji.201444999","article-title":"Development of thymic Foxp3(+) regulatory T cells: TGF-beta matters","volume":"45","author":"Chen","year":"2015","journal-title":"Eur. J. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102066_bib47","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.4049\/jimmunol.0803143","article-title":"Activin a promotes the TGF-beta-induced conversion of CD4+CD25- T cells into Foxp3+ induced regulatory T cells","volume":"182","author":"Huber","year":"2009","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib48","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1615\/CritRevImmunol.v31.i1.50","article-title":"Role of activin A in the induction of Foxp3+ and Foxp3- CD4+ regulatory T cells","volume":"31","author":"Huber","year":"2011","journal-title":"Crit. Rev. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1444533","article-title":"Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense","volume":"15","author":"Yue","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.coi.2011.07.002","article-title":"Histone\/protein deacetylases control Foxp3 expression and the heat shock response of T-regulatory cells","volume":"23","author":"Beier","year":"2011","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2019.101324","article-title":"Epigenetic and transcriptional mechanisms for the regulation of IL-10","volume":"44","author":"Zhang","year":"2019","journal-title":"Semin. Immunol."},{"issue":"14","key":"10.1016\/j.smim.2026.102066_bib52","doi-asserted-by":"crossref","first-page":"E2891","DOI":"10.1073\/pnas.1616942114","article-title":"Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses","volume":"114","author":"Tousa","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102066_bib53","article-title":"Epigenetic signature and key transcriptional regulators of human antigen-specific type 1 regulatory T cells","author":"Cepika","year":"2024","journal-title":"bioRxiv"},{"issue":"7","key":"10.1016\/j.smim.2026.102066_bib54","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10875-019-00684-7","article-title":"Regulatory T cells: the many faces of Foxp3","volume":"39","author":"Georgiev","year":"2019","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib55","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3389\/fimmu.2012.00030","article-title":"The cellular and molecular mechanisms of immuno-suppression by human type 1 regulatory T cells","volume":"3","author":"Gregori","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib56","unstructured":"ALACI, editor 14th Latin American and Caribbean Congress of Immunology2024."},{"issue":"9","key":"10.1016\/j.smim.2026.102066_bib57","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1016\/j.transproceed.2010.08.037","article-title":"High levels of IDO-expressing CD16+ peripheral cells, and Tregs in graft biopsies from kidney transplant recipients under belatacept treatment","volume":"42","author":"Furuzawa-Carballeda","year":"2010","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.smim.2026.102066_bib58","doi-asserted-by":"crossref","first-page":"219","DOI":"10.3389\/fimmu.2017.00219","article-title":"Methylation of FOXP3 TSDR underlies the impaired suppressive function of tregs from long-term belatacept-treated kidney transplant patients","volume":"8","author":"Alvarez Salazar","year":"2017","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib59","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/256960","article-title":"Peripheral regulatory cells immunophenotyping in kidney transplant recipients with different clinical profiles: a cross-sectional study","volume":"2012","author":"Furuzawa-Carballeda","year":"2012","journal-title":"J. Transplant."},{"issue":"2-3","key":"10.1016\/j.smim.2026.102066_bib60","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.trim.2014.02.002","article-title":"Immunophenotyping of peripheral immunoregulatory as well as Th17A and Th22 cell subpopulations in kidney transplant recipients under belatacept or cyclosporine treatment","volume":"30","author":"Furuzawa-Carballeda","year":"2014","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib61","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/302539","article-title":"De Novo donor-specific HLA antibody development and peripheral CD4(+)CD25(high) cells in kidney transplant recipients: a place for interaction?","volume":"2012","author":"Alberu","year":"2012","journal-title":"J. Transplant."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib62","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.transproceed.2018.01.001","article-title":"Peripheral blood regulatory T cells are diminished in kidney transplant patients with chronic allograft nephropathy","volume":"50","author":"Carmona-Escamilla","year":"2018","journal-title":"Transplant. Proc."},{"issue":"10","key":"10.1016\/j.smim.2026.102066_bib63","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1111\/j.1600-6143.2011.03633.x","article-title":"Intragraft regulatory T cells in protocol biopsies retain foxp3 demethylation and are protective biomarkers for kidney graft outcome","volume":"11","author":"Bestard","year":"2011","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.smim.2026.102066_bib64","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2017.10.008","article-title":"Differential T cell subsets and cytokine profile between steady-state and G-CSF-primed bone marrow and its association with graft-versus-host disease","volume":"63","author":"Leon-Rodriguez","year":"2017","journal-title":"Leuk. Res."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib65","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2217\/imt.14.116","article-title":"Rapamycin-conditioned dendritic cells activated with monophosphoryl lipid-A promote allograft acceptance in vivo","volume":"7","author":"Campos-Acuna","year":"2015","journal-title":"Immunotherapy"},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib66","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1016\/j.transproceed.2009.06.130","article-title":"Transforming growth factor-beta and all-trans retinoic acid generate ex vivo transgenic regulatory T cells with intestinal homing receptors","volume":"41","author":"Moore","year":"2009","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.smim.2026.102066_bib67","doi-asserted-by":"crossref","first-page":"596","DOI":"10.3389\/fimmu.2015.00596","article-title":"Alloreactive regulatory T cells allow the generation of mixed chimerism and transplant tolerance","volume":"6","author":"Ruiz","year":"2015","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib68","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s13770-024-00685-7","article-title":"Implantation of islets co-seeded with tregs in a novel biomaterial reverses diabetes in the NOD mouse model","volume":"22","author":"Elizondo","year":"2025","journal-title":"Tissue Eng. Regen. Med."},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib69","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1016\/j.transproceed.2023.03.074","article-title":"Different patterns of Foxp3 gene expression in pre-and post-transplantation kidney biopsies and the effect of use mammalian target of rapamycin inhibitors","volume":"55","author":"Caldas","year":"2023","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib70","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14336\/AD.2018.0318","article-title":"Aging and end stage renal disease cause a decrease in absolute circulating lymphocyte counts with a shift to a memory profile and diverge in treg population","volume":"10","author":"Freitas","year":"2019","journal-title":"Aging Dis."},{"issue":"12","key":"10.1016\/j.smim.2026.102066_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014264","article-title":"Prolonged survival of allografts induced by mycobacterial Hsp70 is dependent on CD4+CD25+ regulatory T cells","volume":"5","author":"Borges","year":"2010","journal-title":"PLoS. One"},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s12879-017-2406-9","article-title":"Severe type 1 upgrading leprosy reaction in a renal transplant recipient: a paradoxical manifestation associated with deficiency of antigen-specific regulatory T-cells?","volume":"17","author":"Vieira","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"4","key":"10.1016\/j.smim.2026.102066_bib73","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/j.1600-6143.2006.01704.x","article-title":"Pathological and clinical correlates of FOXP3+ cells in renal allografts during acute rejection","volume":"7","author":"Veronese","year":"2007","journal-title":"Am. J. Transplant."},{"issue":"7","key":"10.1016\/j.smim.2026.102066_bib74","doi-asserted-by":"crossref","first-page":"805","DOI":"10.6061\/clinics\/2012(07)17","article-title":"The imbalance between Treg and Th17 cells caused by FTY720 treatment in skin allograft rejection","volume":"67","author":"Commodaro","year":"2012","journal-title":"Clin. (Sao Paulo)"},{"issue":"10","key":"10.1016\/j.smim.2026.102066_bib75","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1590\/S0100-879X2012007500089","article-title":"Prolonged acceptance of skin grafts induced by B cells places regulatory T cells on the histopathology scene","volume":"45","author":"Langier","year":"2012","journal-title":"Braz. J. Med. Biol. Res."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib76","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1182\/bloodadvances.2017011072","article-title":"Immune rebound associates with a favorable clinical response to autologous HSCT in systemic sclerosis patients","volume":"2","author":"Arruda","year":"2018","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0307534","article-title":"Low regulatory T-cells frequency is associated with graft rejection after small bowel transplantation: clinical and experimental evidence","volume":"20","author":"Papa-Gobbi","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.smim.2026.102066_bib78","first-page":"3","article-title":"Inmunosupresi\u00f3n en donantes renales expresi\u00f3n de citoquinas proinflamatorias","volume":"72","author":"Federico Cicora","year":"2012","journal-title":"Medicina 2012"},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib79","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.trim.2008.02.003","article-title":"Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells","volume":"19","author":"Velasquez-Lopera","year":"2008","journal-title":"Transpl. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.biosystems.2023.104889","article-title":"Modeling the interaction between donor-derived regulatory T cells and effector T cells early after allogeneic hematopoietic stem cell transplantation","volume":"227-228","author":"Nishiyama","year":"2023","journal-title":"Biosystems"},{"issue":"8","key":"10.1016\/j.smim.2026.102066_bib81","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.ajt.2024.01.006","article-title":"Advancing mouse models for transplantation research","volume":"24","author":"Cravedi","year":"2024","journal-title":"Am. J. Transplant."},{"issue":"12","key":"10.1016\/j.smim.2026.102066_bib82","doi-asserted-by":"crossref","first-page":"a015495","DOI":"10.1101\/cshperspect.a015495","article-title":"Lessons and limits of mouse models","volume":"3","author":"Chong","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.smim.2026.102066_bib83","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cyto.2018.09.013","article-title":"IFN-gamma and IL-33 modulate mesenchymal stem cells function targeting Th1\/Th17 axis in a murine skin transplantation model","volume":"111","author":"Terraza","year":"2018","journal-title":"Cytokine"},{"issue":"16","key":"10.1016\/j.smim.2026.102066_bib84","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1182\/bloodadvances.2023009885","article-title":"Incidence, clinical presentation, risk factors, outcomes, and biomarkers in de novo late acute GVHD","volume":"7","author":"Akahoshi","year":"2023","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib85","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/j.seminhematol.2013.03.026","article-title":"Mouse models in bone marrow transplantation and adoptive cellular therapy","volume":"50","author":"Arber","year":"2013","journal-title":"Semin. Hematol."},{"issue":"12","key":"10.1016\/j.smim.2026.102066_bib86","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1097\/TP.0b013e3181ff8772","article-title":"Ex vivo-expanded human regulatory T cells prevent the rejection of skin allografts in a humanized mouse model","volume":"90","author":"Issa","year":"2010","journal-title":"Transplantation"},{"issue":"83","key":"10.1016\/j.smim.2026.102066_bib87","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci. Transl. Med."},{"issue":"11","key":"10.1016\/j.smim.2026.102066_bib88","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1111\/ajt.12433","article-title":"Clinical grade manufacturing of human alloantigen-reactive regulatory T cells for use in transplantation","volume":"13","author":"Putnam","year":"2013","journal-title":"Am. J. Transplant."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib89","doi-asserted-by":"crossref","DOI":"10.1080\/15476278.2022.2164159","article-title":"Clinical manufacturing of regulatory T cell products for adoptive cell therapy and strategies to improve therapeutic efficacy","volume":"19","author":"Baron","year":"2023","journal-title":"Organogenesis"},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib90","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.immuni.2011.12.012","article-title":"Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells","volume":"36","author":"Miyao","year":"2012","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib91","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/eji.200838105","article-title":"DNA methylation controls Foxp3 gene expression","volume":"38","author":"Polansky","year":"2008","journal-title":"Eur. J. Immunol."},{"issue":"12","key":"10.1016\/j.smim.2026.102066_bib92","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1084\/jem.20110466","article-title":"Dendritic cells induce antigen-specific regulatory T cells that prevent graft versus host disease and persist in mice","volume":"208","author":"Sela","year":"2011","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.smim.2026.102066_bib93","doi-asserted-by":"crossref","first-page":"6329","DOI":"10.4049\/jimmunol.1100061","article-title":"IL-2 controls the stability of Foxp3 expression in TGF-beta-induced Foxp3+ T cells in vivo","volume":"186","author":"Chen","year":"2011","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib94","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.4049\/jimmunol.175.5.3053","article-title":"Expansion of functional endogenous antigen-specific CD4+CD25+ regulatory T cells from nonobese diabetic mice","volume":"175","author":"Masteller","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.smim.2026.102066_bib95","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1084\/jem.193.11.1303","article-title":"Ex vivo isolation and characterization of CD4(+)CD25(+) T cells with regulatory properties from human blood","volume":"193","author":"Dieckmann","year":"2001","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.smim.2026.102066_bib96","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.4049\/jimmunol.167.3.1245","article-title":"CD4+CD25high regulatory cells in human peripheral blood","volume":"167","author":"Baecher-Allan","year":"2001","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.smim.2026.102066_bib97","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/MOT.0b013e328355a992","article-title":"Regulatory T-cell therapy for transplantation: how many cells do we need?","volume":"17","author":"Tang","year":"2012","journal-title":"Curr. Opin. Organ. Transplant."},{"key":"10.1016\/j.smim.2026.102066_bib98","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.717594","article-title":"Antigen specific regulatory T cells in kidney transplantation and other tolerance settings","volume":"12","author":"Hu","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib99","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.661875","article-title":"Antigen-specific regulatory T cell therapy in autoimmune diseases and transplantation","volume":"12","author":"Selck","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.893576","article-title":"A novel GMP protocol to produce high-quality treg cells from the pediatric thymic tissue to be employed as cellular therapy","volume":"13","author":"Bernaldo-de-Quiros","year":"2022","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib101","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1182\/bloodadvances.2020003219","article-title":"First-in-human phase 1 trial of induced regulatory T cells for graft-versus-host disease prophylaxis in HLA-matched siblings","volume":"5","author":"MacMillan","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.smim.2026.102066_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1675114","article-title":"Regulatory T cell therapies: from patient data to biological insights","volume":"16","author":"Rodrigues","year":"2025","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.smim.2026.102066_bib103","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.immuni.2018.12.001","article-title":"The biology of T regulatory type 1 cells and their therapeutic application in immune-mediated diseases","volume":"49","author":"Roncarolo","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.smim.2026.102066_bib104","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3389\/fimmu.2014.00016","article-title":"Immunological outcome in haploidentical-HSC transplanted patients treated with IL-10-Anergized Donor T Cells","volume":"5","author":"Bacchetta","year":"2014","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib105","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1053\/j.gastro.2012.07.116","article-title":"Safety and efficacy of antigen-specific regulatory T-cell therapy for patients with refractory Crohn's disease","volume":"143","author":"Desreumaux","year":"2012","journal-title":"Gastroenterology"},{"issue":"617","key":"10.1016\/j.smim.2026.102066_bib106","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf5264","article-title":"Alloantigen-specific type 1 regulatory T cells suppress through CTLA-4 and PD-1 pathways and persist long-term in patients","volume":"13","author":"Chen","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.smim.2026.102066_bib107","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1604483","article-title":"Treg cell therapy manufacturability: current state of the art, challenges and new opportunities","volume":"16","author":"Stoops","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/978-1-0716-0759-6_14","article-title":"Chimeric antigen receptor (CAR) T cell therapy for cancer. challenges and opportunities: an overview","volume":"2174","author":"Cortes-Hernandez","year":"2021","journal-title":"Methods Mol Biol"},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib109","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/imr.13254","article-title":"Eras of designer Tregs: harnessing synthetic biology for immune suppression","volume":"320","author":"Tuomela","year":"2023","journal-title":"Immunol. Rev."},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib110","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1182\/blood-2004-09-3579","article-title":"Immunotherapy of autoimmune encephalomyelitis with redirected CD4+CD25+ T lymphocytes","volume":"105","author":"Mekala","year":"2005","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.smim.2026.102066_bib111","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1038\/mt.2014.41","article-title":"Suppression of murine colitis and its associated cancer by carcinoembryonic antigen-specific regulatory T cells","volume":"22","author":"Blat","year":"2014","journal-title":"Mol. Ther."},{"issue":"9","key":"10.1016\/j.smim.2026.102066_bib112","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1038\/gt.2009.75","article-title":"Redirecting human CD4+CD25+ regulatory T cells from the peripheral blood with pre-defined target specificity","volume":"16","author":"Hombach","year":"2009","journal-title":"Gene Ther."},{"key":"10.1016\/j.smim.2026.102066_bib113","unstructured":"Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients (STEADFAST) [Internet]. 2025. Available from: http:\/\/clinicaltrials.gov\/study\/NCT04817774."},{"issue":"14","key":"10.1016\/j.smim.2026.102066_bib114","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2219086120","article-title":"Tonic-signaling chimeric antigen receptors drive human regulatory T cell exhaustion","volume":"120","author":"Lamarche","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.smim.2026.102066_bib115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.smim.2026.102066_bib116","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajt.2023.01.030","article-title":"Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity","volume":"23","author":"Larson","year":"2023","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.smim.2026.102066_bib117","unstructured":"Trasplantes. SdSCNd. 2025."},{"key":"10.1016\/j.smim.2026.102066_bib118","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1062456","article-title":"Highly purified and functionally stable in vitro expanded allospecific Tr1 cells expressing immunosuppressive graft-homing receptors as new candidates for cell therapy in solid organ transplantation","volume":"14","author":"Arteaga-Cruz","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib119","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12967-017-1133-8","article-title":"Generation of donor-specific Tr1 cells to be used after kidney transplantation and definition of the timing of their in vivo infusion in the presence of immunosuppression","volume":"15","author":"Mfarrej","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.smim.2026.102066_bib120","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1789008","article-title":"CD25(+)CD27(+)CD70(-) alloantigen-specific Tregs: promising stable immunotherapy for transplantation","volume":"17","author":"Cortes-Hernandez","year":"2026","journal-title":"Front. Immunol."},{"key":"10.1016\/j.smim.2026.102066_bib121","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2026.1827886","article-title":"Increased phenotypic and functional stability of human allospecific induced Tregs is associated with Vitamin C-mediated FOXP3 TSDR demethylation","volume":"17","author":"Alvarez-Salazar","year":"2026","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.smim.2026.102066_bib122","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/MOT.0000000000000483","article-title":"Guiding regulatory T cells to the allograft","volume":"23","author":"Lamarche","year":"2018","journal-title":"Curr. Opin. Organ. Transplant."},{"issue":"3","key":"10.1016\/j.smim.2026.102066_bib123","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.immuni.2008.12.022","article-title":"Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response","volume":"30","author":"Zhang","year":"2009","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.smim.2026.102066_bib124","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1172\/JCI67226","article-title":"Harnessing FOXP3+ regulatory T cells for transplantation tolerance","volume":"124","author":"Waldmann","year":"2014","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.smim.2026.102066_bib125","article-title":"Regulatory T cell therapy in solid organ transplantation: mechanisms, translational progress, and remaining barriers","volume":"17","author":"Yang","year":"2026","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.smim.2026.102066_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24021752","article-title":"Treg Therapy for the Induction of Immune Tolerance in Transplantation-Not Lost in Translation?","volume":"24","author":"Pilat","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.smim.2026.102066_bib127","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s10561-020-09891-8","article-title":"Current concepts for tissue transplant services for developing countries","volume":"22","author":"Verdugo-Avello","year":"2021","journal-title":"Cell. Tissue Bank."}],"container-title":["Seminars in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044532326000539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:48:15Z","timestamp":1791323295000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044532326000539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":127,"alternative-id":["S1044532326000539"],"URL":"https:\/\/doi.org\/10.1016\/j.smim.2026.102066","relation":{},"ISSN":["1044-5323"],"issn-type":[{"value":"1044-5323","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Power to the Tregs in transplantation tolerance in LATAM: From the basics to the bedside","name":"articletitle","label":"Article Title"},{"value":"Seminars in Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smim.2026.102066","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102066"}}